Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence

Journal of Medical Screening

Volumn 15, Issue 4, 2008, Pages 175-181

  Grazzini, Grazia ^a   Ciatto, Stefano ^a   Cislaghi, Cesare ^b   Castiglione, Guido ^a   Falcone, Manuele ^c   Mantellini, Paola ^a   Zappa, Marco ^a   Bonanomi, Andrea Giovanni ^a   Confortini, Massimo ^a   Rubeca, Tiziana ^a   Visioli, Carmen Beatriz ^a  

^a Istituto Toscano Tumori   (Italy)

^b National Agency for Regional Health Services   (Italy)

^c Regional Agency for Healthcare Services of Tuscany   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FRANCE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; OCCULT BLOOD; ADENOMA; COLONOSCOPY; COLORECTAL TUMOR; ECONOMICS; ITALY; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PREDICTION AND FORECASTING; STATISTICS;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; ITALY; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS;

EID: 62749142584     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2008.008032     Document Type: Article

References (21)

1. International Agency for Research on Cancer. Cancer Incidence, Mortality and Prevalence in the European Union, EUCAN 1997 Estimates. 2002. See http://www-dep.iarc.fr/eucan/eucan.htm (last accessed on 15 February 2008)
2. Arbyn M, Van Oyen H, Lynge E, et al. European Commission's proposal for a council recommendation on cancer screening. Br Med J 2003;327:289-290 (Pubitemid 36951609)
3. Raccomandazioni per la pianificazione e l'esecuzione degli screening di popolazione per la prevenzione del cancro della mammella, del cancro della cervice uterina e del cancro del colon retto. Dipartimento Generale delle Prevenzione, Ministero della Salute, November 2006 See www. osservatorionazionalescreening.it/ons/documentazione/raccomandazioni.htm (last accessed on 15 February 2008)
4. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 1996;334:155-159 (Pubitemid 26017953)
5. Castiglione G, Zappa M, Grazzini G, et al. Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests. J Med Screen 2000;7:35-37 (Pubitemid 30305465)
6. Zorzi M, Barca A, Falcini F, et al. Screening for colorectal cancer in Italy: 2005 survey. Epidemiol Prev 2007;31 (Suppl. 2):49-60
7. Castiglione G, Zappa M, Grazzini G, et al. Cost analysis in a population-based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing. J Med Screen 1997;4:142-146 (Pubitemid 28270254)
8. Zappa M, Castiglione G, Paci E, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the district of Florence experience. Int J Cancer 2001;92:151-154 (Pubitemid 32187045)
9. Castiglione G, Visioli CB, Ciatto S, et al. Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme. Br J Cancer 2007;96:1750-1754 (Pubitemid 46847191)
10. Zappa M, Cecchini S, Ciatto S, et al. Measurement of the cost of screening for cervical cancer in the district of Florence, Italy. Tumori 1998;84:631-635 (Pubitemid 29086516)
11. Spagnolo G, Zappa M, Paci E, et al. Evaluation of the costs of mammographic screening program in the city of Florence. Epidemiol Prev 1995;19:330-337
12. Grazzini G, Castiglione C, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 2004;13:19-26 (Pubitemid 38328115)
13. Drummond MF. Principles of Economical Appraisal in Health Care. New York: Oxford Medical, 1980
14. Inadomi JM. Update on the cost-effectiveness of screening for colorectal neoplasia. Curr Opin Gastroenterol 2003;19:44-50 (Pubitemid 36005861)
15. Ramsey SD, Mandelson MT, Berry K, et al. Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology 2003;125:1645-1650 (Pubitemid 37500428)
16. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002;16:96-104
17. Sonnenberg A. Cost-effectiveness in the prevention of colorectal cancer. Gastroenterol Clin North Am 2002;31:1069-1091 (Pubitemid 35403515)
18. Lieberman D. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995;109:1781-1790
19. Whynes DK. Cost-effectiveness of screening for colorectal cancer: evidence from the Nottingham faecal occult blood trial. J Med Screen 2004;11:11-15 (Pubitemid 38365689)
20. Vanara F, Senore C, Segnan N. Screening del cancro colorettale valutazione dei costi. CPO Quaderni, N.9 Torino, Gennaio, 2005
21. Denis B, Ruetsch M, Strentz P, et al. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 2007;56:1579-1584 (Pubitemid 350033197)